TickerSutra

NSE: PRAVEG · BSE: 531637 · ISIN INE722B01019

Praveg Limited stock analysis

Praveg Limited ranks #1997 in the TickerSutra evidence-ranked universe with a score of 49/100 and 91% data confidence. The latest captured fundamentals show ROCE of 1.7%, quarterly sales growth of 16.8% and quarterly profit growth of -120.2%.
Complete evidence gate pass governance reviewUpdated 29 Sept 2026
TICKERSUTRA SCORE49/100

Avoid / exit review

#1997 of 5,430 ranked equities
Market capitalisation₹707.09cr
ROCE1.7%
Quarterly sales growth16.8%
Quarterly profit growth-120.2%
P/E ratio0.0×
Promoter pledge0.0%

INVESTMENT EVIDENCE

What supports—and challenges—the thesis

Evidence in favour

  • Strong CFO/EBITDA of 1.03×
  • 42.1% three-year sales CAGR
  • CWIP indicates an active capacity pipeline
  • No promoter shares are reported as pledged

Risks and constraints

  • Operating margin has compressed materially

Still unresolved: Related-party exposure · Broad media sentiment

FINANCIAL TRAJECTORY

Recent operating history

PeriodRevenueOperating profitNet profitOperating margin
2022₹45cr₹20cr₹12cr44.0%
2023₹84cr₹45cr₹28cr53.0%
2024₹92cr₹29cr₹13cr32.0%
2025₹167cr₹51cr₹16cr30.0%
2026₹241cr₹58cr₹-10cr24.0%
TTM₹248cr₹56cr₹-17cr22.0%
Debt / equity0.38×
CFO / EBITDA1.03×
Operating margin22.0%
Free cash flow₹-61cr
Sales CAGR · 3Y42.1%
Profit CAGR · 3YUnavailable

EXCHANGE EVENT TRIGGERS

Latest corporate disclosures

0 positive catalysts0 negative catalysts4 routine filings

MANAGEMENT COMMENTARY

Signals from filed documents

Regulatory updatesModerate severity · 32 mentions
Constructive

Management continues to follow robust risk management practices and adapts its strategies proactively to address these risks. INTERNAL CONTROL SYSTEMS AND ADEQUACY Praveg Limited maintains a comprehensive framework of internal controls designed to support operational efciency, protect Company assets, guard against fraud and errors, and ensure adherence to statutory and regulatory requirements as well as internal cor

Regulatory approvalModerate severity · 11 mentions
Watch

The project is expected to further strengthen the Company's presence in the North-Eastern region and contribute to its long-term growth strategy. c) Preferential Issue / Fund Raising Subsequent to the end of the nancial year, the Board of Directors, at its meeting held on July 22, 2026, approved the issuance of up to 8,33,700 Equity Shares and 11,00,000 Convertible Warrants on a preferential basis, subject to applic

Capacity expansion plansModerate severity · 2 mentions
Positive catalyst

c) Preferential Issue / Fund Raising Subsequent to the end of the nancial year, the Board of Directors, at its meeting held on July 22, 2026, approved the issuance of up to 8,33,700 Equity Shares and 11,00,000 Convertible Warrants on a preferential basis, subject to applicable statutory and regulatory approvals, including approval of the shareholders and such other approvals as may be required. The proposed issue is

Export market updatesLow severity · 2 mentions
Watch

These forward-looking statements are subject to a number of risks, uncertainties and other factors which could cause actual results to differ materially from those suggested by forward looking statements. Important factors that could inuence the Company’s operation can be affected by global and domestic demand / supply and price conditions in the domestic and overseas markets in which the Company operates changes in

Institutional interestLow severity · 1 mention
Watch

Details of agreements entered into with the media companies and/or their associates NA 17. Schedule of analyst or institutional investor meet and Presentations prepared by the listed entity for analysts or institutional investors meet, post earnings or quarterly calls prior to beginning of such events Yes https://www.dizcoverpraveg.com/shareholders-information 18. Audio recordings, video recordings, if any, and trans

HOW TO READ THIS PAGE

Evidence, freshness and limitations

What does the TickerSutra score mean?

The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.

Which sources support this page?

Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.

Why can an item be unresolved?

Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.

Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer

DIRECTOR & BUSINESS NETWORK

Loading corporate intelligence

Loading universe coverage and exchange-backed evidence…